AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Aug 6, 2018
31949_dirs_2018-08-06_c959032a-fe16-40ea-8477-910d53441f6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-08-02
Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-02 | Ordinary Shares | S | 5336 | $35.00 | Disposed | 110008 | Direct |
| 2018-08-02 | Ordinary Shares | S | 1790 | $35.05 | Disposed | 108218 | Direct |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3